Glial-Cell-Line-Derived Neurotrophic Factor (GDNF) is the major mesenchyme-derived regulator of ureteric budding and branching during nephrogenesis. The ligand activates on the ureteric bud epithelium a receptor complex composed of Ret and GFRa1. The upstream regulators of the GDNF receptors are poorly known. A Notch ligand, Jagged1 (Jag1), co-localises with GDNF and its receptors during early kidney morphogenesis. In this study we utilized both in vitro and in vivo models to study the possible regulatory relationship of Ret and Notch pathways. Urogenital blocks were exposed to exogenous GDNF, which promotes supernumerary ureteric budding from the Wolffian duct. GDNF-induced ectopic buds expressed Jag1, which suggests that GDNF can, directly or indirectly, up-regulate Jag1 through Ret/GFRa1 signalling. We then studied the role of Jag1 in nephrogenesis by transgenic mice constitutively expressing human Jag1 in Wolffian duct and its derivatives under HoxB7 promoter. Jag1 transgenic mice showed a spectrum of renal defects ranging from aplasia to hypoplasia. Ret and GFRa1 are normally downregulated in the Wolffian duct, but they were persistently expressed in the entire transgenic duct. Simultaneously, GDNF expression remained unexpectedly low in the metanephric mesenchyme. In vitro, exogenous GDNF restored the budding and branching defects in transgenic urogenital blocks. Renal differentiation apparently failed because of perturbed stimulation of primary ureteric budding and subsequent branching. Thus, the data provide evidence for a novel crosstalk between Notch and Ret/GFRa1 signalling during early nephrogenesis. q
Introduction
The Wolffian duct is formed from the intermediate mesoderm by mesenchyme-to-epithelium conversion. The duct then proliferates, elongates caudally and finally reaches the cloaca (Obara-Ishihara et al., 1999) . Development of the permanent kidney, the metanephros, begins when the nephrogenic mesenchyme induces ureteric budding from the Wolffian duct in E10.5 mouse. Subsequent ureteric branching giving rise to the collecting duct network is controlled by reciprocal interactions between ureteric bud epithelium, nephrogenic mesenchyme and peritubular stroma. The ureteric bud tips induce a set of metanephric mesenchymal cells to form cap condensates (Sariola, 2002) . Pretubular aggregates evolve from a subset of cap cells, which undergo mesenchyme-to-epithelium transformation to become secretory nephrons (for reviews, see Kuure et al., 2000; Dressler, 2002; Vainio and Lin, 2002; Vize, 2003) .
Glial-Cell-Line-Derived Neurotrophic Factor (GDNF) is already expressed at low level by the uninduced metanephric mesenchyme, but becomes highly up-regulated in the cap condensates (Hellmich et al., 1996; Sainio et al., 1997 Both gene ablation and organ culture studies have shown that GDNF is indispensable for ureteric budding and branching (Durbec et al., 1996; Moore et al., 1996; Pichel et al., 1996; Sainio et al., 1997; Davies, 2003) . On the Wolffian duct-derived epithelium the ligand binds to and activates a receptor complex consisting of Ret receptor tyrosine kinase and GDNF family receptor a1 (GFRa1) (Airaksinen and Saarma, 2002) . GDNF-induced Ret activation regulates the expression of Wnt11 (Pepicelli et al., 1997; Ehrenfels et al., 1999) , which contributes to the regulation of ureteric branching (Majumdar et al., 2003) . Peritubular renal stroma is also involved in the regulation of the ureteric branching. The stromal cells convert vitamin A to retinoic acid, which controls the expression of Ret in the ureteric bud tips by an unknown mechanism (Mendelsohn et al., 1999; Batourina et al., 2001) . Transcription factors and regulators, such as WT1, Pax2, Eya1 and Six2 (Carroll and McMahon, 2003) , are expressed by the metanephric mesenchyme prior to, or shortly after the primary ureteric budding. Pax2, Eya1 and Six2 may control GDNF expression (Xu et al., 1999; Brophy et al., 2001; Brodbeck et al., 2004) and Sprouty1 is needed for GDNFmediated kidney induction (Basson et al., 2005) , but nothing is known about the regulation of the GDNF receptors.
Notch receptors (Notch 1-4) and two groups of ligands, Delta-like (Dll1-2) and Jagged (Jagged1-2), are crucial for multiple processes in animal development. Ligand binding to Notch results in proteolytic cleavage and nuclear translocation of the receptor's intracellular domain. In the nucleus, this domain interacts with the transcription factor Suppressor of Hairless (SuH) and regulates the expression of the transcriptional repressors encoded by the Hairy/ Enhancer of split (Hes) complex (for a review, see Artavanis-Tsakonas et al., 1999) . Hes1 is a direct target of Notch signalling and inhibits differentiation in many tissues (Ohtsuka et al., 2001; Zine et al., 2001; Hirata et al., 2001; Kabos et al., 2002; Wu et al., 2003) . The expression of another family member, Hes6, is not induced by Notch signalling (Koyano-Nakagawa et al., 2000) . In addition, Hes6 does not bind to DNA, but it forms a complex at least with Hes1 (Cossins et al., 2002) to antagonise its repression activity and actually promote differentiation (Gratton et al., 2003) .
In hypomorphic Notch2 mice, reduced Notch2 expression leads to renal hypoplasia and disrupts glomerular development (McCright et al., 2001) . Inhibition of the proteolytic cleavage of Notch results in retarded ureteric branching, perturbs glomerulogenesis and segment specific patterning of secretory nephrons (Cheng et al., 2003; Wang et al., 2003) . In human, mutations in the Jag1 gene cause the autosomal dominant Alagille syndrome with developmental abnormalities in several organs including the kidney (Li et al., 1997; Oda et al., 1997) . Heterozygous Jag1 mice exhibit only the eye defects characteristic of Alagille patients, whereas Jag1 and Notch2 compound heterozygotes (McCright et al., 2001 (McCright et al., , 2002 as well as zebrafish models (Lorent et al., 2004) recapitulate all characteristics of the syndrome including defects in kidney differentiation and maturation, further suggesting that Jagged1 is a ligand for Notch2 during kidney development. Homozygous mice lacking Jag1 die prior to the initiation of kidney morphogenesis due to vascular defects (Xue et al., 1999 ). In addition, two different Jag1 mutations have been created by ENU mutagenesis, but neither slalom (Tsai et al., 2001) nor headturner ) mice help to elucidate the role of Jagged1 in kidney morphogenesis because of early embryonic lethality.
Similarly to GDNF, Jag1 is expressed in the nephrogenic mesenchyme immediately after the initial differentiation of the intermediate mesoderm and later in the metanephric cap condensates. In explant culture, GDNF induces supernumerary budding form the Wolffian duct (Sainio et al., 1997) , and we show that Jag1 is expressed in the tips of these buds. In order to approach the possible crosstalk between Ret and Notch signalling, we created transgenic mice constitutively expressing Jag1 in the entire Wolffian duct under HoxB7 promoter (Kress et al., 1990; Vogels et al., 1993; Srinivas et al., 1999a) . Jag1 transgenic mice were born alive but approximately 40% of the puppies died during the first postnatal day due to renal hypodysplasia or aplasia. The GDNF receptors Ret and GFRa1 were continuously expressed by the entire transgenic duct at the same time when GDNF was not upregulated in the mesenchyme. The renal morphogenesis was restored by exogenous GDNF in explant culture. Thus, the studies in explant culture and Jag1 transgenic mice provide evidence for a crosstalk between Ret and Notch pathways in the control of the ureteric budding and branching.
Results

Expression of Jag1 and its regulation during early nephrogenesis
Jag1 is dynamically expressed during early steps of the kidney development. Prior to the ureteric budding, at E10, Jag1 was highly expressed in the mesonephric tubules, faintly in the cranial Wolffian duct and in periductal cells, but not in the Wolffian duct at the site of future metanephros (data not shown). At E10.5, Jag1 was expressed by both the Wolffian duct and ureteric bud (Fig. 1A) . Immediately when the tip of the ureteric bud started to expand to form subsequently a T-shaped bud, Jag1 was only seen in the tip of the bud, but was absent from the ureteric stalk and its close proximity in the Wolffian duct. Simultaneously, Jag1 became gradually upregulated in the metanephric mesenchyme and was highly expressed in the peritubular mesenchyme around the Wolffian duct (Fig. 1B) .
To study the regulation of Jag1 during ureteric budding, urogenital block explants were exposed to GDNF-releasing beads. When such a bead is placed adjacent to a Wolffian duct in E11 urogenital explants, supernumerary buds are formed (Sainio et al., 1997, see also Fig. 9B) . In situ hybridisation showed that Jag1 was expressed by these buds (Fig. 1C,D) .
Continuous Jag1 expression in the Wolffian duct and its derivatives results in renal malformations
To explore, what happens when Jag1 is constitutively expressed in the entire Wolffian duct, and its developmental downregulation is prevented, transgenic mice expressing human Jag1 cDNA under HoxB7 promoter ( Fig. 2A) were produced by pronuclear micro-injections of the construct into hybrid mouse zygotes (DBA/C57BL/6). Ten viable and fertile founders were detected by PCR, and two (K7L1 and K7L2) lines were studied further. Both displayed similar range of renal malformations indicating that the phenotype was caused by the transgene expression. The expression of the Jag1 transgene was studied with a human-specific Jag1 cRNA probe under high stringency conditions. The transgene was expressed in the Wolffian duct and ureteric bud (Fig. 2B ) consistent with reported HoxB7 promoter activity (Kress et al., 1990; Vogel et al., 1993; Srinivas et al., 1999a) . In situ hybridisation with a human specific cRNA at E12 detects no Jag1 in a wild type kidney, whereas in the Wolffian duct the transgene expression is high. Abbreviations: WT, wild type; TG, transgenic; meta, metanephros. Bar: 100 mm.
The transgenic mice revealed a range of renal malformations (Fig. 3) . At E18, some transgenic kidneys were hypoplastic (Fig. 3A) , others exhibited hydroureters, hydropelvises and tubular cysts ( Fig. 3B-E) . Unilateral aplasia was often accompanied by contralateral renal hypodysplasia (Fig. 3D) . Most severely affected animals had uni-or bilateral renal aplasia (Fig. 3D,F) . Hypoplastic kidneys showed histologically normal nephrons, but exhibited occasionally tubular cysts (Fig. 4A-D) or double ureters and pelvis duplications (Fig. 3E) . Severely hypodysplastic kidneys consisted of only a few nephrons with glomerular and tubular cysts (Fig. 4F) .
The relative transgene copy number was measured by quantitative real-time PCR against a single copy number gene BNP from E18 transgenic embryos (nZ30). In the K7L1 line the highest copy number was three (nZ15; 13%) whereas in the K7L2 line (nZ15) as much as 73% of the animals had three to five transgene copies in their genomes. Two or less copies were present in 87% of the animals in K7L1 and in 27% in K7L2. The majority of the mice in K7L1 had only one transgene copy (67%) whereas in K7L2 no single-copy carriers were identified. The difference in the transgene copy number frequencies was statistically significant (c 2 -test, P!0.005). The incidence of different phenotypes also varied between the two lines. 50% of the animals in K7L1 (nZ15) and 85% in K7L2 (nZ27) had renal aplasia, unilateral aplasia combined with malformations in the contralateral kidney, hypodysplasia, hydroureters, hydropelvises or tubular cysts. In the K7L1 line 50% and in the K7L2 line 15% of mice showed mild renal hypoplasia or no phenotype at all. The differences in the incidence of the phenotype between the two lines were also statistically significant (z-ratio test, P!0.05). Thus, there was a tendency towards more severe renal phenotypes in the higher transgene copy number mouse line (K7L2). It should be noted that the gene copy numbers are not absolute when assayed by real-time PCR.
We measured by quantitative RT-PCR the expression level of a direct Notch downstream target, Hes1, from wild type and Jag1 transgenic kidneys undergoing nephrogenesis at E12 (nZ4). In the transgenic kidneys, the expression level of Hes1 was 1.9-fold as compared to that in the wild type kidneys (P! 0.001, T-test) suggesting that Notch pathway was overactivated in the transgenic kidneys.
The effect of the genetic background on the phenotype was explored by crossing of K7L2 line to NMRI background. After five generations, the phenotype remained the same as in the original line except for a slight decrease in bilateral aplasia and increased incidence of tubular cysts (data not shown).
Ureteric budding and branching are impaired in transgenic Jag1 mice
Renal aplasia and hypodysplasia could result from impaired ureteric budding and branching, defects in the differentiation of the metanephric mesenchyme, or both. These alternatives were first explored by culturing microdissected E11 urogenital blocks from wild type and transgenic mice (nZ26 in both groups) for 3-72 h. After 3 h in culture, a wild type kidney was typically at T-bud stage (Fig. 5A) . After 72 h, the bud had undergone several rounds of branching and induced nephron differentiation as shown by the appearance of proximal-tubule-specific brush border epitopes (Fig. 5B) . No apparent branching defects were seen in 29% of the transgenic explants. In 42%, ureteric budding was initiated during explant culture ( Fig. 5C ), but showed retarded branching (Fig. 5D ). In 29% of transgenic urogenital blocks there was no ureteric bud at E11 (Fig. 5E ) or it was a rudimentary bleb (see also Fig. 6B ). Neither branching nor formation of secretory nephrons was observed during culture of such explants (Fig. 5F ).
We next studied by marker gene analyses and tissue recombination, whether the transgenic metanephric mesenchyme was committed to nephrogenesis and able to differentiate to secretory nephrons. WT1 (data not shown) and Eya1 (Fig. 6A) were expressed in the metanephric mesenchyme in all different phenotypic variations of the Jag1 transgenic kidneys. Also, Pax2 mRNA ( Fig. 6A ) and protein distribution (data not shown) were normal. Six2 expression was slightly reduced in the transgenic kidneys with a ureteric bud (Fig. 6A, left) .
To test if the transgenic metanephric mesenchyme is capable of undergoing nephron differentiation, kidney rudiments were recombined in vitro with a piece of spinal cord (Fig. 6B) , a well-known heterologous inducer of kidney tubulogenesis (Grobstein, 1956; Saxen, 1987) . E11 urogenital blocks were dissected and put into a culture system, where one block was recombined with the inducer tissue and the contralateral block from the same animal served as a control for spontaneous tubulogenesis. We detected spontaneous tubulogenesis only in 50% of the transgenic kidneys (nZ18) in this experiment, whereas all mesenchymes recombined with spinal cord (100%) showed tubulogenesis suggesting that the transgenic mesenchyme had retained its capacity to differentiate into secretory nephrons. The statistical propability for spontaneous tubulogenesis to occur in every transgenic kidney was 0.13% (Fisher's test) supporting the significance of the observed difference. Therefore, these results suggest that the renal malformations in Jag1 mice are due to defects in the control of ureteric budding and branching rather than in mesenchymal differentiation.
Notch signalling in the transgenic kidneys
Jag1 transgenic mice revealed two types of kidney rudiments at E11; those with a normal ureteric bud and those without one or with a very rudimentary bud. When a morphologically normal ureteric bud was present, the expression of all studied Notch pathway molecules was similar to that in wild type kidneys (data not shown).
Upon induction of the nephrogenic mesenchyme, Jag1 became highly upregulated in the wild type cap condensates and the transcripts were also detected in peritubular mesenchyme surrounding Wolffian duct (Fig. 7A ). In the transgenic kidneys without a bud, the expression was restricted to the Wolffian duct epithelium and periductal mesenchyme. No Jag1 was expressed by the metanephric mesenchyme (Fig. 7B) . At the same stage, Notch2 was expressed in the wildtype Wolffian duct and the nephrogenic mesenchyme (Fig. 7C) . The receptor was seen in the E11 transgenic Wolffian ducts, but in the metanephric mesenchyme only when a ureteric bud was present (Fig. 7D) . Wild-type cap condensates expressed Hes1 (Fig. 7E) and Hes6 (Fig. 7G) , which both were also expressed in the tips of the ureteric buds (Fig. 7E ,G, see also Piscione et al., 2004) . In the transgenic kidneys with a rudimentary ureteric bud, no Hes1 (Fig. 7F ) expression was seen in the metanephric mesenchyme, but it was high in ureteric bud tips and the Wolffian duct. Similarly, Hes6 was expressed in the ureteric bud and Wolffian duct epithelium, but the transcripts were also detected in the metanephric mesenchyme that did not form cap condensates (Fig. 7H) .
Abnormal expression of GDNF and its receptors in transgenic Jag1 kidneys
From E10 onwards, the uninduced metanephric mesenchyme expresses GNDF at low level, which becomes highly up-regulated in the mesenchymal cap condensates upon induction ( Fig. 8A ; Hellmich et al., 1996; Suvanto et al., 1996) . At E11, GDNF expression was undetectable in Jag1 transgenic kidneys (nZ4) by in situ hybridisation (Fig. 8B) , even when a ureteric bud (insert) was present. Quantitative RT-PCR confirmed the decreased GDNF level, which was in average 70% lower than in wild type kidneys at E11 (nZ6, P!0.001, T-test). At E12, a very low GDNF expression was detected by in situ hybridisation in one out of five transgenic kidneys undergoing renal development (data not shown), but not in the others.
The GDNF receptor Ret is initially expressed along the entire Wolffian duct, but becomes rapidly down-regulated from the duct at E11 after the first round of ureteric branching (Pachnis et al., 1993) . Thereafter, the expression remains only in the ureteric bud tips and no Ret is detected in the wild type metanephric mesenchyme (Fig. 8C) . In the transgenic kidneys, Ret was continuously expressed by the Wolffian duct and ureter (Fig. 8D) , as well as in a spotted pattern in the urogenital mesenchyme. Neither an epithelial marker pan-cytokeratin nor a neuronal marker neurofilament medium chain were detected in these mesenchymal Ret-expressing cells by immunohistochemistry (data not shown), suggesting that they neither represent scattered ureteric bud cells nor differentiated neuronal cells. GFRa1 is co-expressed with Ret in the Wolffian-duct-derived epithelium, but is additionally expressed in the mesenchymal cap condensates ( Fig. 6E and Suvanto et al., 1996) . Similarly to Ret (Fig. 8D) , GFRa1 expression persisted in the entire Wolffian duct and did not become restricted to ureteric bud tips in the transgenic mice (Fig. 8F) . Because Ret/GFRa signalling can up-regulate Wnt11 in the ureteric bud tips (Pepicelli et al., 1997; Ehrenfels et al., 1999) , we studied the expression of Wnt11 and another epithelial Wnt, Wnt6 (Itäranta et al., 2002) . Both showed normal expression patterns in the transgenic urogenital area from E11 to E18 (data not shown). Also, stromal markers Foxd1 and retinaldehyde dehydrogenase 2 were normally distributed in transgenic kidneys (data not shown).
GDNF rescues ureteric budding and branching
Because the GDNF expression level was low in the transgenic kidneys, we tested if exogenous GDNF could rescue the impaired ureteric budding and branching. A GDNF-releasing bead was placed on a urogenital block, while a BSA-soaked bead was placed on the contralateral urogenital block of the same embryo (nZ 14). Ureteric budding failed in 50% of the BSA-treated transgenic explants, while GDNF-releasing beads restored 
asterisks). (E)
GFRa1 is down-regulated in the wild-type Wolffian duct (arrow) and is maintained in the tips of the branching ureteric bud. Unlike Ret, GFRa1 is also expressed by the cap condensates at the T-bud stage. (F) In transgenic kidneys without a bud, GFRa1 expression is maintained in the entire Wolffian duct (arrow), and low level of expression is also seen in the metanephric mesenchyme. Abbreviations: u, ureter; TG, transgenic; Wd, Wolffian duct; WT, wild type. Bar: 100 mm.
primary ureteric budding in all transgenic explants (Fig. 9A) . In situ hybridisation revealed up-regulation of endogenous Jag1 expression in the ureteric bud tips of rescued explants (data not shown). The ureteric bud branched in 10 out of 14 GDNF-exposed kidneys, while only one BSA-treated explant showed ureteric branching after 48 h of culture.
Exogenous GDNF induces supernumerary budding from the Wolffian duct (Sainio et al., 1997) . The number of GDNFinduced ectopic buds was counted in transgenic and wild type urogenital explants cultured for 48 h, after which the buds were visualised by a Ret cRNA probe (Fig. 9A) . Transgenic Wolffian ducts (nZ6) developed in average 10.3 extra buds while the wild type ones only 7.2 (nZ5) (P!0.02, T-test). The GDNF-induced budding from the Wolffian duct was not only significantly enhanced in the transgenic kidneys, but the buds formed secondary branches as shown in the segment of Wolffian duct in Fig. 9B (arrows) , which was not seen in any of the wild type explants.
Discussion
GDNF and its receptors Ret and GFRa1 are the main positive regulators of primary ureteric budding and subsequent branching. GDNF is expressed by the metanephric mesenchyme and the receptors by the target tissues, the Wolffian duct and ureteric bud epithelium. GDNF/Ret signalling is a classic example of inductive signals regulating organogenesis. Surprisingly little is known about the up-stream regulation of the GDNF receptors. We now provide evidence by explant culture and transgenic Fig. 9 . Exogenous GDNF rescues ureteric budding in transgenic kidneys. (A) GDNF induces ureteric budding in all transgenic explants and rescues the branching defect to level of wild type kidneys in most explants. Albumin (BSA)-soaked beads were used as controls. (B) Ret transcripts visualise the supernumerous ureteric buds induced by GDNF-releasing beads (upper row) in the segment of Wolffian duct. In the wild type Wolffian ducts exposed to GDNF, Ret is expressed only in the buds (black arrows) but not by the Wolffian duct either in GDNF-or BSA-treated explants (white arrowheads). In the transgenic explants exposed to GDNF, Ret expression is seen in the ectopic ureteric buds (black arrowheads) and in buds undergoing secondary branching (black arrows) as well as in the Wolffian duct (white arrowhead). Note that in the transgenic mice some buds have undergone secondary branching (the bud in the middle of the Fig. 9B , upper right corner), which is not seen in GDNF-induced extra buds in the wild type explants. The transgenic controls with BSAsoaked beads also express Ret in the entire Wolffian duct (white arrowhead). The asterisk marks non-epithelial Ret expression. Abbreviations: WT, wild type; TG, transgenic; B, bead, WD, Wolffian duct. Bar in A: 200 mm, in B: 75 mm.
mice that GDNF/Ret and Jagged1/Notch signalling crosstalk in the control of ureteric bud formation.
Jag1 expression in ureteric budding
Ret/GFRa1 and Notch pathway molecules are co-expressed in the whole nephrogenic area immediately after the differentiation of the intermediate mesoderm. Jag1 shows a dynamic expression pattern in the early embryonic kidney, where it co-localises with both the GNDF receptors in the Wolffian duct and ureteric bud, and with GDNF in the metanephric cap condensates. Later during nephrogenesis, Jag1 expression remains high in the comma and S-shaped bodies of the pretubular mesenchyme (Leimeister et al., 2003) . We show that Jag1 expression is, directly or indirectly, upregulated in the ectopic ureteric buds induced by GDNF-releasing beads. Thus, this suggests that Ret/ GFRa1 signalling is biologically upstream to Jag1 during early ureteric bud morphogenesis.
Ureteric budding requires local modulators
To study the role of Jagged1-activated Notch signalling and its possible interaction with Ret and GFRa1 in early kidney development, Jag1 was constitutively expressed in the Wolffian duct epithelium and its derivatives under HoxB7 promoter, which has been widely used in studies on ureteric budding and branching (Srinivas et al., 1999a, b; Chi et al., 2004) . The GDNF receptors were continuously expressed by the transgenic Wolffian duct and its derivatives. Although Ret and GFRa1 were expressed in the entire Wolffian duct, exogenous GDNF induced supernumerary budding and not general broadening of the epithelium. Accordingly, transgenic mice misexpressing GDNF by the entire Wolffian duct epithelia under HoxB7 promoter develop numerous extra buds that express Ret only in the bud tips (R. Shakya and F. Costantini, personal communication) . Both transgenic models indicate that even though Ret/GFRa1 signalling is indispensable for ureteric budding (Schuchardt et al., 1994; Cacalano et al., 1998) , other molecules are involved in the bud shaping. Notch signalling is involved for instance in the lateral inhibition of neural placode in Drosophila (reviewed by Artavanis-Tsakonas et al., 1995) , and it would be reasonable to assume that similar mechanism could affect ureter bud shaping. However, this hypothesis does not gain support from the Jag1 mice, because also their Wolffian ducts develop supernumerary buds instead of general broadening in response to GDNF.
Reduced GDNF causes renal aplasia in Jag1 transgenic mice
The Jag1 mice showed a variety of renal malformations and almost half of the puppies died during the first postnatal day due to renal aplasia or severe hypodysplasia. Tissue recombination experiments showed that the transgenic mesenchyme had retained competence to undergo full epithelial differentiation. In spite of this, GDNF expression remained very low and was detectable by in situ hybridisation only in one out of five transgenic kidneys, which underwent differentiation. In accordance, quantitative RT-PCR showed that GDNF level was reduced in transgenic kidneys at E11 and E12 (data not shown). The low GDNF level most probably caused the failure in ureteric budding and branching, because they both were rescued by exogenous GDNF. Notably, the renal malformations in Jag1 mice recapitulate those reported from the GDNF-deficient mice (Pichel et al., 1996) ; complete loss of gene results in lack of ureter while deletion of one allele causes similar phenotype as observed in lower transgene copy number in Jag1 mice. This supports the idea of haploinsufficiency of GDNF and Jag1 in kidney differentiation (Pichel et al., 1996; McCright et al., 2002) .
Because the transgene is only expressed by the Wolffian duct and its derivatives, the low GDNF level in the metanephric mesenchyme must be a secondary event.
With the current data we can conclude that the low level is not caused by the lack of known transcriptional regulators of GDNF, as Eya1, Pax2 and Six2 were present in the transgenic kidney mesenchyme. It is also unlikely that Notch activity itself would affect directly GDNF expression, because the expression remained low even in the transgenic kidneys were differentiation took place and Notch pathway molecules were expressed by the cap condensates. Low metanephric GDNF levels have also been reported from several other transgenic models for renal development (Srinivas et al., 1999b; Chi et al., 2004; Michos et al., 2004) , but the mechanism has remained unknown. The widespread GDNF receptor expression together with the low GDNF level compromise Ret activation, and thereby disrupt primary ureteric budding in the Jag1 mice.
Hes1 is up-regulated in Jag1 transgenic Wolffian duct
It has been earlier demonstrated that Notch signalling is crucial for the differentiation of the metanephric mesenchyme (McCright et al., 2001 (McCright et al., , 2002 Cheng et al., 2003; Wang et al., 2003) . The lack of Notch pathway molecules in the metanephric mesenchyme of the Jag1 transgenic kidneys without a ureteric bud may reflect failed induction. This gains support from the GNDF restoration and spinal cord recombination experiments, where Jag1 and Notch2 were upregulated both in wild type and transgenic mesenchyme (data not shown). In addition, Jagged1 may have cellautonomous effect through the PDZ-domain found in the C-terminus of the protein (Hock et al., 1998) as shown by overexpression in rat kidney epithelial (RKE) cells (Ascano et al., 2003) . Such an effect could affect the ureteric epithelium and disturb the action of unknown ureter-derived inducer of the metanephric mesenchyme. It is also possible that collecting duct defects in Jag1 mice are caused by a cell-autonomous effect of Jagged1, but this remains hypothetical.
Hes1 is a direct downstream target of the Notch pathway and its expression is induced by Notch activation (Ohtsuka et al., 1999) . Hes1 acts as a transcriptional repressor, which for example in neuronal system prevents the expression of proneural genes and thereby inhibits differentiation (Chen et al., 1997) . Hes6 expression is not induced by Notch activity (Koyano-Nakagawa et al., 2000) and when expressed in the same cells with Hes1, Hes6 antagonises the repressor activity of Hes1 (Bae et al., 2000; Gratton et al., 2004) . In this situation Notch activity promotes differentiation. We quantified the expression level of Hes1 by quantitative RT-PCR in Jag1 transgenic kidneys. Its level was approximately two fold higher in transgenic than wild type kidneys. The enhanced expression of Hes1 indicates that Notch signalling was active in the transgenic Wolffian duct epithelium. Because Hes6 was co-expressed with Hes1 both in wild type and transgenic kidneys, it is possible that the transcriptional repressor effect of Hes1 is abolished by Hes6. As a consequence of Notch activity, the normal downregulation of GDNF receptors from the transgenic Wolffian duct and ureteric bud stalk did not take place. It remains to be studied, whether Hes1 and Hes6 directly or indirectly regulate the expression of the GDNF receptor, but at least Ret promoter contains the binding sequence for Hes1 (nucleotides 3099-3105 in genebank accession number AY255629). However, the Ret promoter elements driving the expression to the developing kidney have not yet been characterised (Sukumaran et al., 2001 ).
Transgenic metanephric mesenchyme contains Ret-expressing cells
Ret transcripts were also detected in a subset of cells in the transgenic urogenital mesenchyme. These Ret-positive cells did not express epithelial or neuronal differentiation markers. These cells may rather represent increased number of neural precursors, a few of which are seen in the normal kidney rudiments (Sariola et al., 1988) . Because spinal cord efficiently induced epithelial differentiation of the transgenic mesenchymes and GDNF restored kidney morphogenesis, it is apparent that the Ret-positive cells do not critically contribute to the renal malformations in Jag1 kidneys.
Crosstalk in Notch and Ret signalling
Because Jag1 is expressed in the GDNF-induced ectopic buds, it is likely that Jagged1 is biologically downstream to Ret signalling. The ectopic buds express the same molecules as the normal ureteric bud, which also expresses Jag1. It is therefore plausible to assume that GDNF, directly or indirectly, induces Jag1 also during primary ureteric budding. Because constitutive expression of Jag1 in the transgenic Woffian duct maintained GDNF receptor expression, Notch and Ret apparently form an autoregulatory loop. This brings us with a model, in which GDNF signalling through Ret/GFRa1 first upregulates Jag1 in the ureteric bud epithelium. Jagged1 then binds to and activates Notch signalling in the tip of ureteric bud, which upregulates Hes1, and it (possibly together with Hes6) reciprocally maintains Ret and GFRa1 expression. By this way Notch signalling provides the tip identity for the ureteric bud cells, which continue their branching until the last metanephric mesenchymal cells have been induced, and GDNF expression ceases. During normal kidney morphogenesis the downregulation of Ret and GFRa1, as well as Jag1, coincides with the change of the cellular identity from tip to stalk. The stalk cells are unable to undergo branching but elongate. It remains to be seen, how constitutive Jag1 expression perturbs GDNF expression by the metanephric mesenchyme, but the lack of GDNF activated Ret/GFRa1 signalling is apparently the main cause for renal malformations in this transgenic model.
Experimental procedures
Generation of transgenic mouse lines
The transgene construct was based on the HoxB7 promoter plasmid (Srinivas et al., 1999a) , in which we inserted a 4.9 kb HindIII human Jag1 cDNA followed by human b-globin 3 0 to provide splice acceptor and donor sites. Vector backbones were removed prior to injections as indicated in Fig. 1A .
Transgenic animals were generated by the standard methods (Hogan et al., 1994) . Potential founders were screened by PCR for transgene integration with primers annealing to the end of HoxB7 promoter (5 0 GAGGCCGT-CATACCATTG 3 0 ) and to the beginning of hJag1 cDNA (5 0 TGATCGCTTCTTTGAGACGC) (Fig. 1A) . The transgene-positive founders were bred with wild type C57BL/6 mice for eight to nine generations. Some transgenic mice in C57BL/6 were bred for five generations with out-bred NMRI mice to test the effect of the background strain.
Quantitative real-time PCR
Genomic DNA from tail biopsies was isolated for quantitative PCR analysis according to standard protocol (Hogan et al., 1994) . ABI 7700 Sequence Detection System using TaqMan chemistry was used to detect the relative transgene copy numbers. Quantitative PCR was carried out with primers specific for human Jag1 cDNA and the resulting amplicon was detected with a bifunctional fluorogenic probe. The results were normalised to single copy B-type natriuretic peptide (BNP) gene quantified from the same samples. Forward and reverse primers and probes for hJag1 transgene copy number detection were 5 0 -ACACACACTCAGCCTCTGAGGAC-3 0 , w Reagent (Gibco BRL). The contralateral kidney rudiment was used for in vitro branching morphogenesis analysis. Due to small sample size, 5 mg LPA, 250 ng tRNA and 0.5 ml Pellet paint co-precipitant (Novagen) were used as carriers to help the precipitation, otherwise the isolation was performed according manufacturers instructions. RNA was purified with Rneasy MinElute Cleanup system (Qiagen) and the yield measured with 2100 Bioanalyzer (Agilent Tech.). 50 ng of total RNA was reverse transcribed with anchored oligo-dT primer using Transcriptor First Strand cDNA Synthesis Kit (Roche Diagnostics). Serial dilutions (0.4 pg, 40 fg, 4 fg and 0.4 fg) were made from plasmids corresponding the quantified gene.
PCR reactions were performed in the LightCycler (LC) apparatus using the LC FastStart DNA Master SYBR Green I Kit (Roche Diagnostics). Thermocycling was done in a final volume of 20 ml containing 2 ml of cDNA sample (or standard), 4 mM (Hes1) or 5 mM (GDNF and G3PDH) of MgCl 2 , 0.3 mM of each primer and 1x ready-to-use reaction mix including Taq DNA polymerase, SYBR Green fluorescence dye, reaction buffer, and dNTP mix. After 10 min of initial denaturation at 95 8C, the cycling conditions were: 95 8C for 10 s, annealing at 56 8C (for Hes1) or 54 8C (for GDNF) or 62 8C (for G3PDH), and elongation at 72 8C for 8, 20 and 21 s, respectively. Total number of cycles was 45 for Hes1 and G3PDH and 48 for GDNF. The LightCycler apparatus measured the fluorescence of each sample at the end of the annealing step during every cycle. After proportional background adjustment, the fit point method was used to determine the cycle in which the log-linear signal was distinguished from the background, and that cycle number was used as the crossing-point value. The software produced the standard curve by measuring the crossing point of each standard and plotting them against the logarithmic values of concentrations. The expression levels of Hes1 and GDNF were normalized by the housekeeping gene G3PDH (forw 5 0 ACCACA GTCCATGCCATCAC3 0 , rev 5 0 TCCACC ACCCTGT TGCTGTA3 0 ).
Histological analysis, organ culture and immunohistochemistry
Whole embryos and urogenital blocks were fixed overnight with 4% PFA and processed for paraffin embedding and sectioning. Hematoxylin-eosin staining was used for histological studies.
For in vitro experiments, urogenital blocks were microdissected in sterile Dulbecco's PBS as described (Sainio, 2003) . For all studies, the urogenital blocks were cut into two halves; one was manipulated and the other served as a control for the experiment. Culture media was DMEM supplemented with 10% fetal bovine serum, Glutamax and penicillin-streptomycin. For induction experiments, the kidney rudiment was recombined with a piece of wild type dorsal spinal cord and explants were cultured for 72 h. In the rescue experiments, either GDNF (50 ng/ml of baculoviral recombinant GDNF kindly donated by Cephalon)-or BSA-soaked heparin beads (Sigma) were placed next to metanephros for 48 h cultures.
Whole-mount immunohistochemistry was performed according to Sariola et al. (1988) . Double antibody labelling with pan-cytokeratin (1:400) (Sigma) and brush border (1:2000) (rabbit polyclonal anti-brush border antibody, a gift from docent Aaro Miettinen) antibodies (Ekblom et al., 1980) was detected with RedX-conjugated secondary antibody against mouse IgG (1:400) and FITC-conjugated anti-rabbit antibody (1:200) (both Jackson ImmunoResearch Lab.), respectively. After whole mount in situ hybridisation, neurofilament 3H2 antibody (1:600, Hybridoma bank) labelling was detected with RedXconjugated secondary antibody against mouse IgG (1:400). Rabbit anti-Pax2 antibody was used at 1:200 (Zymed) and detected by biotinylated anti-rabbit IgG (1:100) with Vectastain ABC Elite Kit (Vector Laboratories Inc.).
In situ hybridisation
Whole-mount in situ hybridisation was performed with InSituPro automate (Intavis). The automate performs hybridisation according to Wilkinson (1993) . All other probes used have been published earlier (mouse Jag1 and Notch2; Mitsiadis et al., 1995 ; a gift from R. Kagayama (XhoI/T3), GDNF; a gift from JG Pichel (NsiI/Sp6) Ret; Pachnis et al., 1993, GFRa1; Suvanto et al., 1997, Pax2; Dressler et al., 1990 , Six2; a gift from RL Maas (EcoRI/T7) Eya1; Xu et al., 1997) except the probe for human Jag1, which was subcloned into pBluescript vector as 1.1 kb EcoRV-StuI fragment corresponding to 5 0 end of the gene. The plasmid was then linearised with NotI and transcribed with T3 RNA polymerase. The sense probe was transcribed with T7 RNA polymerase after HindIII linearisation. The human Jag1 cRNA was first tested in embryonic human kidney sections (data not shown), where it showed the same expression pattern as mouse Jag1 in the mouse kidney.
Probes were hybridised for 16 h at 65 8C except for hJag1 and Shh, which were hybridised at 70 8C. Results were visualised and photographed with Leica microscope equipped with DC300F camera and IM1000 software. For vibratome sectioning, samples were embedded into 0.5% gelatin containing 30% bovine serum albumin and 20% sucrose and cut with Leica VT 1000S Vibratome machine (Leica) into 20-25 mm sections.
